Change of Name

Recorded: 2018-01-18 Pages: 3

Assignor

ORPHAN SYNERGY EUROPE-PHARMA

Executed: 2016-05-31

Assignee

OSE IMMUNOTHERAPEUTICS

22 BOULEVARD BENONI GOULLIN, NANTES, 44200, FRANCE

Covered Property (1)

Tritoqualine for Use in the Treatment of Cystic Fibrosis

Patent: 9,301,955 →

Application: 14/397,743 →

Publication: US 2015/0133487

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.